{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Merck", "item": "https://www.patentleaderboard.com/2021/company/merck"}, {"@type": "ListItem", "position": 4, "name": "Eric Escobar Cabrera", "item": "https://www.patentleaderboard.com/2021/inventor/fl:er_ln:cabrera-1"}]}

Home › 2021 › Merck › Eric Escobar Cabrera

Eric Escobar Cabrera — 1 Patent in 2021

ZYZymeworks: 1 patents #12 of 38Top 35%

Merck: 1 patents #304 of 909Top 35%

Burnaby, CA: #60 of 194 inventorsTop 35%

Overall (2021): #463,700 of 548,734Top 85%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11072658	Anti-PD-1/LAG3 bispecific antibodies	Laurence Fayadat-Dilman, Veronica Juan, Shireen S. Khan, Shaopeng Huang, Hua Ying +1 more	2021-07-27	$304,446,000

Eric Escobar Cabrera — 1 Patent in 2021

Issued Patents 2021

Patent Widget